What is the recommended dosage for Zepbound (generic name) Subcutaneous Solution 7.5 mg Auto-injector?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Zepbound (Tirzepatide) 7.5 mg Auto-injector Dosage Instructions

Zepbound 7.5 mg subcutaneous solution should be administered once weekly using the auto-injector device, injected into the abdomen, thigh, or upper arm.

Administration Instructions

  • Zepbound is administered via subcutaneous injection once weekly, on the same day each week 1
  • The auto-injector should be used to inject into the abdomen, thigh, or upper arm, rotating injection sites with each dose 2
  • The entire contents of the 7.5 mg auto-injector should be administered as a single dose 3
  • The maximum recommended subcutaneous injection volume is generally 1.5 mL, though volumes up to 3.5 mL may be considered in certain circumstances 4

Dosing Considerations

  • The 7.5 mg dose is typically part of a dose escalation regimen for patients with type 2 diabetes or those using the medication for weight management 5
  • No dosage adjustment is required for patients with renal impairment, including those with eGFR ≥20 mL/min per 1.73 m² 5
  • For patients with severe renal impairment (eGFR <30 mL/min), careful monitoring is recommended due to potential delayed drug clearance 5

Potential Adverse Effects

  • Gastrointestinal effects are the most commonly reported adverse events, including nausea, vomiting, diarrhea, and constipation 6
  • Headache, joint pain, and fatigue may also occur during treatment 6
  • In rare cases, more serious adverse events such as pancreatitis have been reported 6
  • There have been case reports of functional small bowel obstruction, even in patients without predisposing factors 1

Important Administration Tips

  • The auto-injector should be allowed to warm to room temperature for approximately 30 minutes before injection 2
  • Visually inspect the solution before administration - it should be clear and colorless to slightly yellow 3
  • Do not use if particulate matter is visible or if the solution is cloudy or discolored 3
  • The injection should be administered into healthy, non-irritated skin, avoiding areas that are bruised, red, or hard 2

Storage Requirements

  • Store the auto-injector in the refrigerator (36°F to 46°F or 2°C to 8°C) 3
  • Do not freeze the medication 3
  • The auto-injector may be kept at room temperature (below 86°F or 30°C) for up to 21 days 3

Always follow the specific instructions provided with the medication packaging and consult with a healthcare provider for personalized guidance on administration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.